Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis.

Baum KJ, Ren R.

J Hematol Oncol. 2008 Jun 5;1:5.

PMID: 18577264 [PubMed - in process]

Related Articles Free article in PMC

Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice.

Pelletier SD, Hong DS, Hu Y, Liu Y, Li S.

Blood. 2004 Oct 1;104(7):2163-71. Epub 2004 Jun 22.

PMID: 15213099 [PubMed - indexed for MEDLINE]

Related Articles

Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia.

Signer RA, Montecino-Rodriguez E, Witte ON, McLaughlin J, Dorshkind K.

Blood. 2007 Sep 15;110(6):1831-9. Epub 2007 Jun 6.

PMID: 17554060 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

The SH2 domain of bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype.

Zhang X, Wong R, Hao SX, Pear WS, Ren R.

Blood. 2001 Jan 1;97(1):277-87.

PMID: 11133772 [PubMed - indexed for MEDLINE]

Related Articles

STAT5 signaling is required for the efficient induction and maintenance of CML in mice.

Ye D, Wolff N, Li L, Zhang S, Ilaria RL Jr.

Blood. 2006 Jun 15;107(12):4917-25. Epub 2006 Mar 7.

PMID: 16522816 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

IRF-4 functions as a tumor suppressor in early B-cell development.

Acquaviva J, Chen X, Ren R.

Blood. 2008 Nov 1;112(9):3798-806. Epub 2008 Aug 19.

PMID: 18713947 [PubMed - indexed for MEDLINE]

Related Articles

High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.

Young FM, Campbell A, Emo KL, Jansson J, Wang PY, Jordan CT, Mullen CA.

Biol Blood Marrow Transplant. 2008 Jun;14(6):622-30. Epub 2008 Apr 14.

PMID: 18489987 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling.

Yan M, Luo JK, Ritchie KJ, Sakai I, Takeuchi K, Ren R, Zhang DE.

Blood. 2007 Jul 1;110(1):305-12. Epub 2007 Mar 20.

PMID: 17374743 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Animal models of chronic myelogenous leukemia.

Ilaria RL Jr.

Hematol Oncol Clin North Am. 2004 Jun;18(3):525-43, vii. Review.

PMID: 15271391 [PubMed - indexed for MEDLINE]

Related Articles

Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.

Lidonnici MR, Corradini F, Waldron T, Bender TP, Calabretta B.

Blood. 2008 May 1;111(9):4771-9. Epub 2008 Jan 28.

PMID: 18227349 [PubMed - indexed for MEDLINE]

Related Articles

Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells.

MacPartlin M, Smith AM, Druker BJ, Honigberg LA, Deininger MW.

Leukemia. 2008 Jul;22(7):1354-60. Epub 2008 Jun 12.

PMID: 18548107 [PubMed - indexed for MEDLINE]

Related Articles

IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.

Wong S, McLaughlin J, Cheng D, Shannon K, Robb L, Witte ON.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11630-5. Epub 2003 Sep 19. Erratum in: Proc Natl Acad Sci USA. 2003 Dec 23;100(26):16143-4.

PMID: 14500898 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Lipocalin 2 is required for BCR-ABL-induced tumorigenesis.

Leng X, Lin H, Ding T, Wang Y, Wu Y, Klumpp S, Sun T, Zhou Y, Monaco P, Belmont J, Aderem A, Akira S, Strong R, Arlinghaus R.

Oncogene. 2008 Oct 16;27(47):6110-9. Epub 2008 Jul 28.

PMID: 18663364 [PubMed - indexed for MEDLINE]

Related Articles

Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.

Wu J, Meng F, Kong LY, Peng Z, Ying Y, Bornmann WG, Darnay BG, Lamothe B, Sun H, Talpaz M, Donato NJ.

J Natl Cancer Inst. 2008 Jul 2;100(13):926-39. Epub 2008 Jun 24.

PMID: 18577747 [PubMed - indexed for MEDLINE]

Related Articles

Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo.

Yu W, Sun X, Clough N, Cobos E, Tao Y, Dai Z.

Carcinogenesis. 2008 Sep;29(9):1717-24. Epub 2008 May 2.

PMID: 18453543 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation.

Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P, Trussell C, Schmitt-Graeff A, Landwerlin K, Veelken H, Warmuth M.

Cancer Cell. 2008 Sep 9;14(3):238-49.

PMID: 18772113 [PubMed - indexed for MEDLINE]

Related Articles

Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis.

Thomas EK, Cancelas JA, Zheng Y, Williams DA.

Leukemia. 2008 May;22(5):898-904. Epub 2008 Mar 20. Review.

PMID: 18354486 [PubMed - indexed for MEDLINE]

Related Articles

CREB is a critical regulator of normal hematopoiesis and leukemogenesis.

Cheng JC, Kinjo K, Judelson DR, Chang J, Wu WS, Schmid I, Shankar DB, Kasahara N, Stripecke R, Bhatia R, Landaw EM, Sakamoto KM.

Blood. 2008 Feb 1;111(3):1182-92. Epub 2007 Nov 1.

PMID: 17975014 [PubMed - indexed for MEDLINE]

Related Articles

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.

Agarwal A, Bumm TG, Corbin AS, O'Hare T, Loriaux M, VanDyke J, Willis SG, Deininger J, Nakayama KI, Druker BJ, Deininger MW.

Blood. 2008 Sep 1;112(5):1960-70. Epub 2008 Jun 17.

PMID: 18559973 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.

Konig H, Copland M, Chu S, Jove R, Holyoake TL, Bhatia R.

Cancer Res. 2008 Dec 1;68(23):9624-33.

PMID: 19047139 [PubMed - in process]

Related Articles